Patents Assigned to Thylabisco AB
  • Patent number: 9333226
    Abstract: The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention also relates to the use of said hydrophobic peptide in a pharmaceutical as well as a food composition and methods of treating a mammal with said composition.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: May 10, 2016
    Assignee: Thylabisco AB
    Inventors: Per-Ake Albertsson, Charlotte Erlansson-Albertsson
  • Patent number: 9186384
    Abstract: The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention also relates to the use of said hydrophobic peptide in a pharmaceutical as well as a food composition and methods of treating a mammal with said composition.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: November 17, 2015
    Assignee: Thylabisco AB
    Inventors: Per-Ake Albertsson, Charlotte Erlansson-Albertsson
  • Publication number: 20140220070
    Abstract: The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention also relates to the use of said hydrophobic peptide in a pharmaceutical as well as a food composition and methods of treating a mammal with said composition.
    Type: Application
    Filed: December 23, 2013
    Publication date: August 7, 2014
    Applicant: Thylabisco AB
    Inventors: Per-Ake ALBERTSSON, Charlotte ERLANSSON-ALBERTSSON
  • Publication number: 20140220084
    Abstract: The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention also relates to the use of said hydrophobic peptide in a pharmaceutical as well as a food composition and methods of treating a mammal with said composition.
    Type: Application
    Filed: December 23, 2013
    Publication date: August 7, 2014
    Applicant: Thylabisco AB
    Inventors: Per-Ake ALBERTSSON, Charlotte ERLANSSON-ALBERTSSON
  • Publication number: 20140037774
    Abstract: Disclosed, is a composition comprising thylakoids, or parts thereof, for reducing the transport of molecules through the intestinal mucosa of the intestinal tract of a mammal.
    Type: Application
    Filed: February 24, 2012
    Publication date: February 6, 2014
    Applicant: THYLABISCO AB
    Inventors: Charlotte Erlanson Albertsson, Per-Ake Albertsson
  • Patent number: 8642098
    Abstract: The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention also relates to the use of said hydrophobic peptide in a pharmaceutical as well as a food composition and methods of treating a mammal with said composition.
    Type: Grant
    Filed: February 24, 2011
    Date of Patent: February 4, 2014
    Assignee: Thylabisco AB
    Inventors: Per-Åke Albertsson, Charlotte Albertsson-Erlanson